0
Clinical Investigations: COPD |

The Effect of Smoking Intervention and an Inhaled Bronchodilator on Airways Reactivity in COPD*: The Lung Health Study

Robert A. Wise; Richard E. Kanner; Paula Lindgren; John E. Connett; Murray D. Altose; Paul L. Enright; Donald P. Tashkin; for the Lung Health Study Research Group
Author and Funding Information

Affiliations: *From the Johns Hopkins University School of Medicine (Dr. Wise), Baltimore, MD; University of Utah School of Medicine (Dr. Kanner), Salt Lake City, UT; University of Minnesota School of Public Health (Ms. Lindgren and Dr. Connett), Minneapolis, MN; Case Western Reserve University (Dr. Altose), Cleveland, OH; University of Arizona (Dr. Enright), Tucson, AZ; and University of California at Los Angeles School of Medicine (Dr. Tashkin), Los Angeles, CA.,  See Appendix for a list of participants in the LHS Research Group.

Correspondence to: Richard E. Kanner, MD, FCCP, University of Utah Health Sciences Center, 26 North 1900 East, Salt Lake City, UT 84132; e-mail: kanner@med.utah.edu


Affiliations: *From the Johns Hopkins University School of Medicine (Dr. Wise), Baltimore, MD; University of Utah School of Medicine (Dr. Kanner), Salt Lake City, UT; University of Minnesota School of Public Health (Ms. Lindgren and Dr. Connett), Minneapolis, MN; Case Western Reserve University (Dr. Altose), Cleveland, OH; University of Arizona (Dr. Enright), Tucson, AZ; and University of California at Los Angeles School of Medicine (Dr. Tashkin), Los Angeles, CA.,  See Appendix for a list of participants in the LHS Research Group.


Chest. 2003;124(2):449-458. doi:10.1378/chest.124.2.449
Text Size: A A A
Published online

Background: The Lung Health Study (LHS), a 5-year, randomized, prospective clinical trial, studied the effects of smoking intervention and therapy with inhaled anticholinergic bronchodilators on FEV1 in participants who were 35 to 60 years of age and had mild COPD. Participants were randomized into the following three groups: usual care; smoking cessation plus inhaled ipratropium bromide; and smoking cessation plus placebo inhaler. This report evaluates the effects of these interventions, demographic characteristics, smoking status, and FEV1 changes on airway responsiveness (AR).

Methods and results: Of 5,887 participants, 4,201 underwent methacholine challenge testing both at study entry and study completion. All groups increased AR during the 5-year period. The increase in AR was greatest in continuing smokers and was associated with a greater FEV1 decline. An intent-to-treat analysis indicated no significant differences in AR changes among the three groups.

Conclusions: Changes in AR over a 5-year period in the LHS were primarily related to changes in the FEV1. The greater the decline in FEV1, the greater the increase in AR. Smoking cessation had a small additional benefit in AR beyond its favorable effects on FEV1 changes.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543